As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >

Media center

Learn more about the recent accomplishments of Genopole’s laboratories, businesses, researchers and entrepreneurs.
Genopole Media Center Genopole Media Center
Key figures
  • +1000

    successful projects

  • 2800

    direct jobs

  • 65


  • 17


Media center

Press Release

Find our latest press releases

Cobioe - Vignette actualités

Genopole and the COBIOE project consortium open an interconnection platform for the European biomanufacturing sector

The COBIOE project aims to build a shared and inclusive strategy for strengthening and interconnecting Europe's healthcare biomanufacturing sector. A part of the Horizon Europe program's European Innovation Ecosystems theme and coordinated by Genopole, the 24-month project is initiating the first step of its Europe-wide interconnection platform for biomanufacturing professionals.

D4Gen Hackathon - Edition 2024 - Rendez-vous à Paris

Genopole is organizing the third edition of the D4Gen Hackathon

On 22–24 March 2024, Genopole will hold its third annual D4Gen Hackathon for innovation in life sciences. Students, researchers and start-uppers will build teams and imagine novel digital solutions to better understand the mechanisms of life and complex systems, to model them and find inspiration therein.

Lauréats de la promo 3 du programme Gene.iO - Genopole

Gene.iO 2023 – 8 award-winning innovative biotechs

October 16, 2023 – 8 innovative biotech companies have just been selected in the 3rd promotion of Genopole's Gene.iO program: they win a year's coaching at the cutting edge of biotech expertise, to help them successfully raise their first funds or sign their first commercial agreement.

Genopole announces 5 i-Lab startup winners - I-lab2023

Genopole announces 5 i-Lab startup winners

July 6, 2023 – Five biotech companies from Genopole, a biocluster dedicated to innovation for health and sustainable development, have won the i-Lab national competition run by Bpifrance and the French Ministry of Higher Education, Research and Innovation, to support the most promising deep-tech companies in France.

3 laureates of the French Government's Major Challenges program

Biopharmaceuticals Major Challenge: The University of Évry and Genopole present in three of the eight laureate projects

ART-TG, CiTHERA, I-Stem and Yposkesi are contributing their expertise to three projects named on 3 February 2022 as laureates for the French Government's Major Challenges program.

IGEM 2021 - Equipe d'Evry

IGEM 2021: Yet another Gold Medal!

19 novembre 2021 – Pour la 5ème année consécutive, l’équipe d’Évry décroche une médaille d’or au célèbre concours international en biologie de synthèse iGEM, grâce à son projet « Evolution T7 » reposant sur l’évolution génétique dirigée et ouvrant un vaste champ d’applications.


Algentech: High-Yield Molecular Farming Of Industrial Ingredients In Plant Chloroplasts

22 juin 2021 – Algentech, a Genopole-accredited French company, has achieved a world's first with its disruptive technology . The company's patented method enables the production of proteins and nucleic acids in plant chloroplasts.

Eu|bic certification

Genopole earns EU|BIC certification

5 décembre 2020 The European Commission's European Business Network (EBN) voted unanimously to certify Genopole as a European Union | Business and Innovation Center (EU|BIC), thus recognizing France's leading biocluster as a key contributor to R&D and Innovation in Genomics in France and Europe.

Covid illustration CP

Enalees announces clinical trial for a COVID-19 test

16 septembre 2020 – C4Diagnostics, Bertin Technologies and Enalees announced the launch of a prospective clinical trial for BEC-SARS-CoV-2 for humans, a rapid, point-of-care diagnostic for COVID-19.


A Friendly Takeover Bid Initiated by OncoDNA on IntegraGen

July 09, 2020 This transaction would bring together OncoDNA’s expertise in oncology precision medicine and IntegraGen’s know-how in DNA sequencing services and bioinformatics analyses. The combination of both companies would enable to offer a complete solution that combines oncology laboratory testing and software solutions which will benefit the treatment of patients with advanced cancer.

Cellules bleues fond parme

AB Science : masitinib’s potential mode of action in Alzheimer’s Disease

July 08, 2020 – AB Science SA announced the publication of preclinical study results with masitinib in Alzheimer’s disease entitled, ‘Effects of chronic masitinib treatment in APPPS1dE9 transgenic mice modeling Alzheimer’s disease’.

Rapport Activité 2019

Ÿnsect obtains market approval for an insect-based fertilizer

17 juin 2020 – Ÿnsect has just gained approval for its natural insect fertilizer “ŸnFrass” issued by ANSES, the French Agency for Food, Environmental and Occupational Health & Safety. Ÿnsect thus becomes the first company in the world to obtain certification and marketing approval for a natural insect-based fertilizer.

Pharnext - Prescribed Drugs

Pharnext – A novel strategy to rapidly reposition drugs using existing COVID-19 clinical data

23 mars 2020 – Pharnext annonce l’identification de 97 médicaments fréquemment prescrits, au moyen de sa plateforme de Pleotherapy, comme candidats potentiels au repositionnement dans le traitement du COVID-19.

Integragen - high throughput sequencing

IntegraGen renews its agreement with the Institut Pasteur

11 mars 2020 – IntegraGen announces the renewal of its partnership agreement with the Institut Pasteur until December 2021 related to high-throughput sequencing operations for microbiology activities carried out at the Institut Pasteur

Algentech-crispr cas9

Algentech Granted US Patent For A Key Genome Editing Technology

16 janvier 2020- Algentech annonce la délivrance d'un brevet clé dans le domaine de l'édition du génome par l'Office des brevets des États-Unis

View all >
Media center


Find our latest publications

Annual Report 2022 - Genopole - France

Annual Report 2022

Annual report: with this document, relive the year 2022 for Genopole and its stakeholders through key figures, testimonials and their news.

The Bioeconomy at Genopole - brochure from the collection "Sectors at Genopole"

Sector : The Bioeconomy

The bioeconomy aims to valorize biomass for the production of materials, nutrition, energy and molecules of industrial interest. At Genopole, a growing number of actors are energizing the development of a sustainable bioeconomy.


Annual Report 2021

Annual Report: in this document, relive the year 2021 for Genopole and its stakeholders through key figures, testimonials and news.

Brochure : Innovative biotherapies - Collection "Sectors at Genopole" - UK 2022

Sector : Innovative Biotherapies

Issues In Biotherapies: A Third Revolution In Therapeutics – Genopole and its actors are able and willing to accompany this revolution and bring answers to the challenges within it. They are helping to build a biotherapies sector.

View all >
Press Contact

Contact us!

You would like information on Genopole, conduct an interview, visit the campus …

Contact us
With the support from
Région île de France